Overview
- Net sales growth (+6.9 %) thanks to organic performance
- EBITDA pre up sharply (+23.8%), organically driven by Life Science and Healthcare
- Business in Asia continues to drive organic sales growth of the Group
- Merck KGaA, Darmstadt, Germany, confirms forecast for sales and earnings performance
We achieved organic sales growth in all regions. The jump in earnings was due to the very good business performance of Life Science as well as the milestone payments in Healthcare. These payments are evidence of our successes in developing innovative medicines.
ADDITIONAL INFORMATION & DOWNLOADS
Half-Yearly Financial Report 2019
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, Sees Profit Jump in Q2
Merck KGaA, Darmstadt, Germany generated strong net sales growth in the second quarter of 2019, primarily on an organic basis.
2019/08/08
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price